0S9E Stock Overview
Through its subsidiaries, provides care and services for seniors in Canada. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 4/6 |
Extendicare Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$9.09 |
52 Week High | CA$9.42 |
52 Week Low | CA$6.63 |
Beta | 1.28 |
11 Month Change | 0% |
3 Month Change | 7.64% |
1 Year Change | n/a |
33 Year Change | 24.86% |
5 Year Change | n/a |
Change since IPO | 21.20% |
Recent News & Updates
Recent updates
Shareholder Returns
0S9E | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0% | 0.6% | 2.2% |
1Y | n/a | -22.6% | 8.0% |
Return vs Industry: Insufficient data to determine how 0S9E performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how 0S9E performed against the UK Market.
Price Volatility
0S9E volatility | |
---|---|
0S9E Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0S9E's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0S9E's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1968 | n/a | Michael Guerriere | www.extendicare.com |
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.
Extendicare Inc. Fundamentals Summary
0S9E fundamental statistics | |
---|---|
Market cap | CA$866.39m |
Earnings (TTM) | CA$63.90m |
Revenue (TTM) | CA$1.42b |
13.6x
P/E Ratio0.6x
P/S RatioIs 0S9E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0S9E income statement (TTM) | |
---|---|
Revenue | CA$1.42b |
Cost of Revenue | CA$1.22b |
Gross Profit | CA$204.05m |
Other Expenses | CA$140.14m |
Earnings | CA$63.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.77 |
Gross Margin | 14.32% |
Net Profit Margin | 4.48% |
Debt/Equity Ratio | 244.3% |
How did 0S9E perform over the long term?
See historical performance and comparisonDividends
4.6%
Current Dividend Yield63%
Payout RatioDoes 0S9E pay a reliable dividends?
See 0S9E dividend history and benchmarksExtendicare dividend dates | |
---|---|
Ex Dividend Date | Nov 29 2024 |
Dividend Pay Date | Dec 16 2024 |
Days until Ex dividend | 4 days |
Days until Dividend pay date | 21 days |
Does 0S9E pay a reliable dividends?
See 0S9E dividend history and benchmarks